This test is most useful if any of these apply to you.
This test reveals something most blood panels never check: how much of two common industrial chemicals, styrene and ethylbenzene, your body has recently absorbed. You take these solvents in from cigarette smoke, certain workplaces, traffic, and some consumer products, and your body turns them into the compound this urine test measures.
That matters because higher levels have been repeatedly linked to real outcomes in people, including type 2 diabetes, osteoarthritis, weaker kidney function, and higher inflammation. A single number gives you a window into an exposure you may not know you have.
This test measures phenylglyoxylic acid (PGA), a breakdown product your body makes after absorbing styrene or ethylbenzene. Once these solvents enter your bloodstream, your body converts them, starting in the liver, into a related compound called mandelic acid and then into PGA, both of which leave the body in urine. A urine level therefore reflects how much solvent you have absorbed, not a chemical your body makes for any healthy purpose of its own.
Because PGA clears quickly, it captures recent exposure, mostly from the same day or the day before, with some carryover overnight. It does not tell you about exposure from months or years ago. Think of it as a snapshot of what you have been breathing lately. In workplace settings, PGA is usually read together with mandelic acid, and occupational safety guidelines are built on the sum of the two.
In a study of about 2,200 adults followed for six years, people with higher combined urine levels of these two solvent metabolites (mandelic acid plus PGA) had a higher risk of both having and developing type 2 diabetes, and the risk climbed step by step as levels rose. The link was stronger in people who also carried a high genetic risk for diabetes. This finding measured the two metabolites together, so it reflects overall styrene and ethylbenzene exposure rather than PGA on its own.
If your level is elevated and you have other metabolic risk factors, it is worth pairing this result with a fasting glucose or HbA1c (a three-month average of your blood sugar) to see the full metabolic picture.
Among roughly 6,600 middle-aged and older US adults, higher urinary PGA and related ethylbenzene metabolites were associated with a greater risk of osteoarthritis. Markers of biological aging appeared to partly explain the connection, suggesting these exposures may nudge joint and tissue aging along. This was an observational snapshot, so it shows a link rather than proof that the chemical causes the disease.
In about 1,160 petrochemical workers, the combined level of mandelic acid and PGA was linked in a straight-line fashion to lower kidney filtration and more frequent mild kidney impairment, and it was one of the main contributors when several solvents were analyzed together. As with the diabetes data, this used the two metabolites summed rather than PGA by itself.
An elevated result alongside any drop in your kidney numbers is a reason to check eGFR (a measure of how well your kidneys filter) and cystatin C (a blood-based kidney marker).
In a study of about 7,000 US adults, urinary PGA and other solvent metabolites showed a positive relationship with whole-body inflammation scores, often in a J-shaped pattern, meaning the lowest and highest exposures carried more inflammation than the middle. The extra inflammation at the lowest exposures is an unusual finding that may partly reflect other differences between those groups rather than the chemical itself. Smokers were more vulnerable to this effect. Because chronic inflammation itself drives many long-term diseases, tracking exposure that feeds it is worthwhile.
Petrochemical workers with higher PGA and related solvent metabolites had higher white blood cell and lymphocyte counts and elevated liver enzymes, pointing toward mild inflammatory and liver effects. These changes were seen in occupational groups with meaningful exposure, not necessarily at the low levels typical of the general public.
The chemicals behind this marker turn up in more places than most people expect.
Because this marker reflects recent exposure, a single measurement mostly tells you about the last day or two. If you are tested right after a heavy-exposure day, the number will look high; test on a quiet weekend and it may look low. That day-to-day swing is exactly why a trend beats a snapshot.
Get a baseline, then retest to see whether the level is consistently elevated or was a one-off. If you make a change like quitting smoking or improving ventilation at work, retest a few weeks later to confirm the exposure has actually fallen. For ongoing monitoring, at least once a year makes sense, and more often if you work around solvents. Repeated or pooled samples describe your true exposure far better than any single reading.
A high level is a signal to hunt for the source, not to panic. Start with the obvious contributors: tobacco smoke, your job, and your home or commuting environment.
Pair the result with companion tests based on your other risks: a fasting glucose or HbA1c if you have metabolic concerns, eGFR and cystatin C if kidney health is a question, and hs-CRP (a sensitive blood test for inflammation) if you want to see whether inflammation is running high. A co-metabolite such as methylhippuric acid can confirm broader solvent exposure. If your level is high and workplace exposure is likely, an occupational or environmental medicine specialist can help assess and reduce it.
Evidence-backed interventions that affect your PGO level
Phenylglyoxylic Acid is best interpreted alongside these tests.
Phenylglyoxylic Acid is included in these pre-built panels.